Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease

NCT ID: NCT06354842

Last Updated: 2024-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-05

Study Completion Date

2020-12-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It has been shown that excretion of sodium and water through the skin in the form of sweat represents a regulatory mechanism of electrolyte- and fluid balance. Since patients with chronic kidney disease (CKD) exhibit increased skin sodium content, we investigated the feasibility of sweat testing as a novel experimental tool to a more complete assessment of fluid- and sodium homeostasis.

In this cross-sectional feasibility study, we applied pilocarpine iontophoresis to induce sweat testing in 58 patients across various stages of CKD including patients after kidney transplantation as well as a healthy control cohort (n=6) to investigate possible effects of CKD and transplantation status on sweat rate and sodium concentration. Due to non-linear relationships, we modeled our data using polynomial regression.

Decline of kidney function showed a significant association with lower sweat rates: adj R²= 0.2278, F(2, 61) = 10.29, p = 0.000141. Sweat sodium concentrations were increased in moderate CKD, however this effect was lost in end stage renal disease: adj R² = 0.3701, F(4, 59) = 10.26, p = 2.261e-06. We observed higher sweat weight in males compared to females.

Diagnostic sweat analysis represents an innovative and promising noninvasive option for more thorough investigation of sodium- and fluid homeostasis in CKD patients. Lower sweat rates and higher sweat sodium concentrations represent a unique feature of CKD patients with potential therapeutic implications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Healthy control subjects

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDI

Patients with chronic kidney disease G1

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDII

Patients with chronic kidney disease G2

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDIIIa

Patients with chronic kidney disease G3a

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDIIIb

Patients with chronic kidney disease G3b

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDIV

Patients with chronic kidney disease G4

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDV

Patients with chronic kidney disease G5

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

CKDVd

Patients with chronic kidney disease G5 receiving hemodialysis

pilocarpine iontopheresis

Intervention Type DIAGNOSTIC_TEST

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pilocarpine iontopheresis

Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Completed 18th year of life and the ability and willingness to provide informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tarik Shoumariyeh

Clinical resident & PhD student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johannes Kovarik, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Shoumariyeh T, Logar F, Helk O, Hofer J, Schmetterer KG, Mersi B, Gruber S, Saemann MD, Kaltenecker CC, Kovarik JJ. Decline of kidney function is associated with lower sweat weight in patients with chronic kidney disease. Sci Rep. 2025 Jul 2;15(1):22518. doi: 10.1038/s41598-025-05855-8.

Reference Type DERIVED
PMID: 40596012 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

12345678

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Saline Infusion Test in Hyponatremia
NCT06498856 NOT_YET_RECRUITING
Acute Salt Handling in Orthostatic Intolerance
NCT00581633 ACTIVE_NOT_RECRUITING NA
Aldosterone in Diabetic Nephropathy
NCT00870402 UNKNOWN PHASE4
Diuretic/Cool Dialysate Trial
NCT02593526 TERMINATED NA